NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF
· Real-Time Price · USD
1.89
-0.03 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
1.86
-1.59%
After-hours: Aug 15, 2025, 07:47 PM EDT
NewGenIvf Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | May 31, 2021 |
Revenue | 1.27M | 1.47M | 1.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 914.18K | 826.65K | 1.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 359.43K | 646.21K | 196.82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.09M | 216.31K | -1.27M | -377.72K | -367K | -510.55K | -115.64K | -106.55K | -122.69K | -160.03K | -80 | -2.01K |
Interest Income | 4.55K | n/a | 122.00 | 504.74K | 452.5K | 562.67K | 590K | 314.87K | 94.15K | 6.53K | n/a | n/a |
Pretax Income | -543K | -30.34K | -955K | 127.02K | 85.5K | 52.12K | 474.36K | 208.32K | -28.54K | -153.5K | -80 | -2.01K |
Net Income | -108K | -19.86K | -955K | 127.02K | 85.5K | 52.12K | 474.36K | 208.32K | -28.54K | -153K | -80 | -2.01K |
Selling & General & Admin | 1.45M | 429.9K | 1.27M | 377.72K | 367K | 510.55K | 115.64K | 106.55K | 122.69K | 160.03K | 80.00 | 2.01K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.45M | 429.9K | 1.27M | 377.72K | 367K | 510.55K | 115.64K | 106.55K | 122.69K | 160.03K | 80.00 | 2.01K |
Interest Expense | 421.11K | 247.91K | 25.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.36M | 1.26M | 1.27M | 377.72K | 367K | 510.55K | 115.64K | 106.55K | 122.69K | 160.03K | 80.00 | 2.01K |
Income Tax Expense | -487K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 569.25K | 363.65K | 253.73K | 135.54K | 135.54K | 135.54K | 217.35K | 217.35K | 217.35K | 135.54K | 37.5M | 37.5M |
Shares Outstanding (Diluted) | 569.25K | 363.65K | 253.73K | 135.54K | 135.54K | 135.54K | 217.35K | 217.35K | 217.35K | 135.54K | 37.5M | 37.5M |
EPS (Basic) | -4.75 | -1.35 | 33.05 | 23.45 | 15.75 | 9.60 | 54.55 | 23.95 | -3.3 | -28.3 | n/a | -0.00 |
EPS (Diluted) | -4.75 | -1.35 | 33.05 | 23.45 | 15.75 | 9.60 | 54.55 | 23.95 | -3.3 | -28.3 | n/a | -0.00 |
EBITDA | 58.33K | 226.87K | 451.85K | 127.02K | 85.5K | 52.12K | 474.36K | 208.32K | -28.54K | -153K | -80 | -2.01K |
EBIT | -121.58K | 217.57K | 284.9K | 127.02K | 85.5K | 52.12K | 474.36K | 208.32K | -28.54K | -153K | -80 | -2.01K |
Depreciation & Amortization | 179.9K | 9.3K | 166.95K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |